106 related articles for article (PubMed ID: 17941040)
1. Anticoagulant effect of sodium dehydroacetate (DHA-S) in rats.
Sakaguchi Y; Suga S; Oshida K; Miyamoto-Kuramitsu K; Ueda K; Miyamoto Y
J Appl Toxicol; 2008 May; 28(4):524-9. PubMed ID: 17941040
[TBL] [Abstract][Full Text] [Related]
2. Sodium dehydroacetate induces coagulation dysfunction by inhibiting liver vitamin K epoxide reductase complex subunit 1 in Wistar rats.
Chen X; Wei Q; Lu Q; Zhao Z; Yu Z; Zhang Y
Res Vet Sci; 2019 Jun; 124():399-405. PubMed ID: 31078787
[TBL] [Abstract][Full Text] [Related]
3. Sodium dehydroacetate-induced disorder of coagulation function in broiler chickens and the protective effect afforded by vitamin K.
Xu J; Hao F; Wang C; Zhao Z; Zhang M; Chen X; Zhang Y
Poult Sci; 2023 Mar; 102(3):102482. PubMed ID: 36706663
[TBL] [Abstract][Full Text] [Related]
4. Serum pharmacokinetics and coagulation aberration induced by sodium dehydroacetate in male and female Wistar rats.
Zhang Y; Ying D; Liu H; Yu Z; Han L; Xie J; Xie Y
Sci Rep; 2017 Apr; 7():46210. PubMed ID: 28387309
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of blood coagulation induced by sodium dehydroacetate via the regulation of the mTOR/ERK pathway in rats.
Zhang M; Zhang Q; Zhao W; Chen X; Zhang Y
Toxicol Lett; 2024 Feb; 392():1-11. PubMed ID: 38103582
[TBL] [Abstract][Full Text] [Related]
6. Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver.
Cain D; Hutson SM; Wallin R
Thromb Haemost; 1998 Jul; 80(1):128-33. PubMed ID: 9684798
[TBL] [Abstract][Full Text] [Related]
7. Depression of liver microsomal vitamin K epoxide reductase activity associated with antibiotic-induced coagulopathy.
Matsubara T; Touchi A; Harauchi T; Takano K; Yoshizaki T
Biochem Pharmacol; 1989 Aug; 38(16):2693-701. PubMed ID: 2764989
[TBL] [Abstract][Full Text] [Related]
8. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
Mosterd JJ; Thijssen HH
J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
[TBL] [Abstract][Full Text] [Related]
9. Sex Metabolic Differences and Effects on Blood Coagulation Among Rats Exposed to Sodium Dehydroacetate.
Chen X; Hao F; Zhang M; Xiao J; Zhao W; Zhao Z; Zhang Y
Front Pharmacol; 2021; 12():727084. PubMed ID: 34594221
[TBL] [Abstract][Full Text] [Related]
10. Phenobarbital (PB)-induced changes in blood coagulationrelated parameters in pregnant rats, lactating rats and pups.
Mochizuki M; Shimizu S; Kidokoro Y; Kamata T; Kitazawa T; Kishi D; Okazaki E; Nishihata Y; Ohishi T
J Toxicol Sci; 2009 Dec; 34(6):603-10. PubMed ID: 19952496
[TBL] [Abstract][Full Text] [Related]
11. A molecular mechanism for genetic warfarin resistance in the rat.
Wallin R; Hutson SM; Cain D; Sweatt A; Sane DC
FASEB J; 2001 Nov; 15(13):2542-4. PubMed ID: 11641264
[TBL] [Abstract][Full Text] [Related]
12. Puerarin offsets the anticoagulation effect of warfarin in rats by inducing rCyps, upregulating vitamin K epoxide reductase and inhibiting thrombomodulin.
Ge B; Zhang Z; Lam TT; Zuo Z
Biopharm Drug Dispos; 2017 Jan; 38(1):33-49. PubMed ID: 27925234
[TBL] [Abstract][Full Text] [Related]
13. Target-based warfarin pharmacokinetics in the rat: the link with the anticoagulant effect.
Thijssen HH; Janssen YP
J Pharmacol Exp Ther; 1994 Aug; 270(2):554-8. PubMed ID: 8071848
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of VKORC1 and VKORC1L1 signaling in the effects of sodium dehydroacetate on coagulation factors in rat hepatocytes.
Zhou Z; Chen B; Zhang M; Chen X; Zhang Y
Toxicol In Vitro; 2023 Mar; 87():105518. PubMed ID: 36403723
[TBL] [Abstract][Full Text] [Related]
15. Altered hemostasis in male rats following administration of the ACAT inhibitor SKF-99085.
Sellers T; O'Brien S; Gossett K; Gunning M; Boram D; Rehm S; Kerns W
Toxicol Sci; 1998 Nov; 46(1):151-4. PubMed ID: 9928678
[TBL] [Abstract][Full Text] [Related]
16. Sodium dehydroacetate induces cardiovascular toxicity associated with Ca
Huang X; Zhao X; Zhu K; Ding S; Shao B
Ecotoxicol Environ Saf; 2021 Jan; 208():111613. PubMed ID: 33396133
[TBL] [Abstract][Full Text] [Related]
17. Establishing a rat model for the study of vitamin K deficiency.
Mi Y; Xiao X; Liu D; Ping N; Zhu Y; Li B; Long L; Cao Y
Int J Exp Pathol; 2016 Apr; 97(2):187-93. PubMed ID: 27256579
[TBL] [Abstract][Full Text] [Related]
18. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.
Choonara IA; Malia RG; Haynes BP; Hay CR; Cholerton S; Breckenridge AM; Preston FE; Park BK
Br J Clin Pharmacol; 1988 Jan; 25(1):1-7. PubMed ID: 3370190
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice.
Sato K; Taniuchi Y; Kawasaki T; Hirayama F; Koshio H; Matsumoto Y; Iizumi Y
Jpn J Pharmacol; 1998 Oct; 78(2):191-7. PubMed ID: 9829622
[TBL] [Abstract][Full Text] [Related]
20. Warfarin resistance in a French strain of rats.
Lasseur R; Longin-Sauvageon C; Videmann B; Billeret M; Berny P; Benoit E
J Biochem Mol Toxicol; 2005; 19(6):379-85. PubMed ID: 16421894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
